INTEGRATED FILING — Other than Banks



General information about company

Scrip code 000000
NSE Symbol CELLPOINT
MSEI Symbol NOTLISTED
ISIN INE0O0001013
Name of Company Cell Point (India) Limited
Type of company SME
Class of security Equity
Date of start of financial year 01-Apr-2024
Date of end of financial year 31-Mar-2025
Date of board meeting when results were approved 29-May-2025
Date on which prior intimation of the meeting for considering financial results was informed to the exchange 16-May-2025
Description of presentation currency INR (in Actuals)
Reporting Type Half Yearly
Reporting Quarter Yearly
Nature of report standalone or consolidated Standalone
Whether results are audited or unaudited for the quarter ended Unaudited
Whether results are audited or unaudited for the Year to date for current period ended/year ended Audited
Segment Reporting Single segment
Description of single segment Retail sales of mobile phones
Start date and time of board meeting 29-May-2025   15:00:00
End date and time of board meeting 29-May-2025   18:15:00
Whether cash flow statement is applicable on company Yes
Type of cash flow statement Cash Flow Indirect
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Whether the company has any related party? Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure? Yes
(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/public NA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of banks staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure. No
(III) Whether the company is a high value debt listed entity according to regulation 15 (1A)? No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company? Yes
Latest Date on which RPT policy is updated 2023-06-28
Indicate Company website link for updated RPT policy of the Company cellpoint.biz
Whether statement on deviation or variation for proceeds of public issue, rights issue, preferential issue, qualified institutions placement etc. is applicable to the company for the current quarter? No
No. of times funds raised during the quarter
Whether the disclosure for the Default on Loans and Debt Securities is applicable to the entity? No
Currently, there are no default on loans


Financial Results — Other than Bank

Particulars 3 months/ 6 months ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
A Date of start of reporting period 01-Oct-2024 01-Apr-2024
B Date of end of reporting period 31-Mar-2025 31-Mar-2025
C Whether results are audited or unaudited Unaudited Audited
D Nature of report standalone or consolidated Standalone Standalone
Part I Blue color marked fields are non-mandatory. For Consolidated Results, if the company has no figures for 3 months / 6 months ended, in such case zero shall be inserted in the said column.
1 Revenue From Operations
Revenue from operations 1711875000 3247058000
Other income 2302000 15528000
Total Income 1714177000 3262586000
2 Expenses
(a) Cost of materials consumed 0 0
(b) Purchases of stock-in-trade 1486031000 2787992000
(c) Changes in inventories of finished goods, work-in-progress and stock-in-trade -63114000 -85560000
(d) Employee benefit expense 60337000 119296000
(e) Finance costs 26824000 51769000
(f) Depreciation and amortisation expense 1034000 32269000
(g) Other Expenses
1 Other Expenses 201565000 352142000
Total other expenses 201565000 352142000
Total expenses 1712677000 3257908000
3 Profit before exceptional and extraordinary items and tax 1500000 4678000
4 Exceptional items 23463000 23463000
5 Profit before extraordinary items and tax 24963000 28141000
6 Extraordinary items 0 0
7 Profit before tax 24963000 28141000
8 Tax Expense
Current tax -5630000 0
Deferred tax 10221000 5526000
Total tax expenses 4591000 5526000
9 Net Profit Loss for the period from continuing operations 20372000 22615000
10 Profit (loss) from discontinuing operations before tax 0 0
11 Tax expense of discontinuing operations 0 0
12 Net profit (loss) from discontinuing operation after tax 0 0
13 Profit (loss) for period before minority interest 20372000 22615000
14 Share of profit (loss) of associates
15 Profit (loss) of minority interest
16 Net profit (Loss) for the period 20372000 22615000
17 Details of equity share capital
Paid-up equity share capital 186856000 186856000
Face value of equity share capital 10 10
18 Reserves excluding revaluation reserve 555683000
19 Earnings per equity share
Basic earnings (loss) per share from continuing and discontinued operations 1.09 1.21
Diluted earnings (loss) per share from continuing and discontinued operations 1.09 1.21
20 Debt equity ratio 0.0061 0.0061
21 Debt service coverage ratio 0.01 0.0208
22 Interest service coverage ratio 0.0106 0.0109
23 Disclosure of notes on financial results


Remarks

20 Debt equity ratio
21 Debt service coverage ratio
22 Interest service coverage ratio


Cash flow statement — indirect

A Date of start of reporting period 01-Apr-2024
B Date of end of reporting period 31-Mar-2025
C Whether results are audited or unaudited Audited
D Nature of report standalone or consolidated Standalone
1 Statement of cash flows
Cash flows from used in operating activities
Profit before extraordinary items and tax 28141000
2 Adjustments for reconcile profit (loss)
Adjustments to profit (loss)
Adjustments for finance costs 35478000
Adjustments for depreciation and amortisation expense 8806000
Adjustments for impairment loss reversal of impairment loss recognised in profit or loss 0
Adjustments for unrealised foreign exchange losses gains 0
Adjustments for dividend income 0
Adjustments for share-based payments 0
Other adjustments for which cash effects are investing or financing cash flow 0
Other adjustments to reconcile profit (loss) 0
Other adjustments for non-cash items 1337000
Share of profit and loss from partnership firm or association of persons or limited liability partnerships 0
Total adjustments to profit (loss) 45621000
3 Adjustments for working capital
Adjustments for decrease (increase) in inventories -85560000
Adjustments for decrease (increase) in trade receivables -7770000
Adjustments for decrease (increase) in other current assets -40297000
Adjustments for increase (decrease) in trade payables 48500000
Adjustments for increase (decrease) in other current liabilities -252000
Adjustments for provisions 4788000
Total adjustments for working capital -80591000
Total adjustments for reconcile profit (loss) -34970000
Net cash flows from (used in) operations -6829000
Dividends received 0
Interest paid 0
Interest received 0
Income taxes paid (refund) 57000
Other inflows (outflows) of cash 0
Net cash flows from (used in) operating activities before extraordinary items -6886000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) operating activities -6886000
4 Cash flows from used in investing activities
Cash flows from losing control of subsidiaries or other businesses 0
Cash flows used in obtaining control of subsidiaries or other businesses 0
Other cash receipts from sales of equity or debt instruments of other entities 0
Other cash payments to acquire equity or debt instruments of other entities 0
Other cash receipts from sales of interests in joint ventures 0
Other cash payments to acquire interests in joint ventures 0
Cash receipts from share of profits of partnership firm or association of persons or limited liability partnerships 0
Cash payment for investment in partnership firm or association of persons or limited liability partnerships 0
Proceeds from sales of property plant and equipment 0
Purchase of property plant and equipment 49988000
Proceeds from sales of intangible assets 0
Purchase of intangible assets 0
Cash advances and loans made to other parties 0
Cash receipts from repayment of advances and loans made to other parties 0
Cash payments for future contracts, forward contracts, option contracts and swap contracts 0
Cash receipts from future contracts, forward contracts, option contracts and swap contracts 0
Dividends received 0
Interest received 0
Income taxes paid (refund) 0
Other inflows (outflows) of cash 73353000
Proceeds from government grants 0
Net cash flows from (used in) investing activities before extraordinary items 23365000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) investing activities 23365000
Cash flows from used in financing activities
Proceeds from issuing shares 0
Proceeds from issuing other equity instruments 0
Proceeds from issuing debentures notes bonds etc 0
Proceeds from borrowings 0
Repayments of borrowings 35330000
Dividends paid 1259000
Interest paid 35478000
Income taxes paid (refund) 0
Other inflows (outflows) of cash 0
Net cash flows from (used in) financing activities before extraordinary items -72067000
Proceeds from extraordinary items 0
Payment for extraordinary items 0
Net cash flows from (used in) financing activities -72067000
Net increase (decrease) in cash and cash equivalents before effect of exchange rate changes -55588000
6 Effect of exchange rate changes on cash and cash equivalents
Effect of exchange rate changes on cash and cash equivalents 0
Net increase (decrease) in cash and cash equivalents -55588000
Cash and cash equivalents cash flow statement at beginning of period 120014000
Cash and cash equivalents cash flow statement at end of period 64426000


Statement of Asset and Liabilities

Particulars Year ended (dd-mm-yyyy)
Date of start of reporting period 01-Apr-2024
Date of end of reporting period 31-Mar-2025
Whether results are audited or unaudited Audited
Nature of report standalone or consolidated Standalone
Equity and liabilities
1 Shareholders' funds
Share capital 186856000
Reserves and surplus 555683000
Money received against share warrants 0
Total shareholders' funds 742539000
2 Share application money pending allotment 0
3 Deferred government grants 0
4 Minority interest
5 Non-current liabilities
Long-term borrowings 8982000
Deferred tax liabilities (net) 0
Foreign currency monetary item translation difference liability account 0
Other long-term liabilities 0
Long-term provisions 6043000
Total non-current liabilities 15025000
6 Current liabilities
Short-term borrowings 443562000
Trade Payables
(A) Total outstanding dues of micro enterprises and small enterprises 50779000
(B) Total outstanding dues of creditors other than micro enterprises and small enterprises 89633000
Total Trade payable 140412000
Other current liabilities 4607000
Short-term provisions 35437000
Total current liabilities 624018000
Total equity and liabilities 1381582000
Assets
1 Non-current assets
i Property, Plant and Equipment and Intangible assets
Property, Plant and Equipment 365413000
Producing properties 0
Intangible assets 0
Preproducing properties 0
Property, Plant and Equipment capital work-in-progress 7933000
Intangible assets under development or work-in-progress 0
Total Property, Plant and Equipment and Intangible assets 373346000
ii Non-current investments 0
v Deferred tax assets (net) 4707000
vi Foreign currency monetary item translation difference asset account 0
vii Long-term loans and advances 0
viii Other non-current assets 214775000
Total non-current assets 592828000
Current assets
Current investments 0
Inventories 636482000
Trade receivables 11782000
Cash and cash equivalents 39512000
Bank balance other than cash and cash equivalents 24914000
Short-term loans and advances 13935000
Other current assets 62129000
Total current assets 788754000
Total assets 1381582000
Disclosure of notes on assets and liabilities


Format for Reporting Segment wise Revenue, Results and Capital Employed along with the company results

Particulars 3 months/ 6 month ended (dd-mm-yyyy) Year to date figures for current period ended (dd-mm-yyyy)
Date of start of reporting period 01-Oct-2024 01-Apr-2024
Date of end of reporting period 31-Mar-2025 31-Mar-2025
Whether results are audited or unaudited Unaudited Audited
Nature of report standalone or consolidated Standalone Standalone
1 Segment Revenue (Income)
(net sale/income from each segment should be disclosed)
Total Segment Revenue
Less: Inter segment revenue
Revenue from operations
2 Segment Result
Profit (+) / Loss (-) before tax and interest from each segment
Total Profit before tax
i. Finance cost
ii. Other Unallocable Expenditure net off Unallocable income
Profit before tax
3 (Segment Asset - Segment Liabilities)
Segment Asset
Total Segment Asset
Un-allocable Assets
Net Segment Asset
4 Segment Liabilities
Segment Liabilities
Total Segment Liabilities
Un-allocable Liabilities
Net Segment Liabilities
Disclosure of notes on segments




Details of Impact of Audit Qualification

Whether results are audited or unaudited Audited
Declaration of unmodified opinion or statement on impact of audit qualification Declaration of unmodified opinion
Auditor's opinion
Declaration pursuant to Regulation 33 (3) (d) of SEBI (LODR) Regulation, 2015: The company declares that its Statutory Auditor/s have issued an Audit Report with unmodified opinion for the period on Standalone results Yes
Sr No. Audit firm's name Whether the firm holds a valid peer review certificate issued by Peer Review Board of ICAI Certificate valid upto
1 M/s Rao & Kumar Yes 31-Jan-2027


Signatory Details

Name of signatory
Designation of person
Place
Date


Format for Disclosure of Related Party Transactions (applicable only for half-yearly filings i.e., 2nd and 4th quarter)

Sr No. Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Details of the party (listed entity /subsidiary) entering into the transaction Details of the counterparty Type of related party transaction Details of other related party transaction Value of the related party transaction as approved by the audit committee Remarks on approval by audit committee Value of the related party transaction ratified by the audit committee Date of Audit Committee Meeting where the ratification was approved Value of transaction during the reporting period In case monies are due to either party as a result of the transaction In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments Details of the loans, inter-corporate deposits, advances or investments Notes
Name PAN Name PAN Relationship of the counterparty with the listed entity or its subsidiary Opening balance Closing balance Nature of indebtedness (loan/ issuance of debt/ any other etc.) Details of other indebtedness Cost Tenure Nature (loan/ advance/ intercorporate deposit/ investment ) Interest Rate (%) Tenure Secured/ unsecured Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1 Cell Point India Limited Mohan Prasad Panday Managing director Remuneration 1200000000000 0 1200000000000 2025-05-29 1200000000000 100000000000 100000000000
2 Cell Point India Limited Mohan Prasad Panday Managing director Any other transaction Rent 240000000000 0 240000000000 2025-05-29 240000000000 20000000000 20000000000
3 Cell Point India Limited Bala Balaji Panday Whole Time director Remuneration 600000000000 0 600000000000 2025-05-29 600000000000 50000000000 50000000000
4 Cell Point India Limited Bala Balaji Panday Whole Time director Any other transaction Rent 120000000000 0 120000000000 2025-05-29 120000000000 10000000000 10000000000
5 Cell Point India Limited Kiranmai Panday Director Remuneration 600000000000 0 600000000000 2025-05-29 600000000000 4900000000 78482700000
6 Cell Point India Limited BBV Manikanta Chief Financial Officer Remuneration 100000000000 0 100000000000 2025-05-29 100000000000 8333333000 8333333000
7 Cell Point India Limited Chandrasekhar Raghavapudi Company Secretary Remuneration 36000000000 0 36000000000 2025-05-29 36000000000 3000000000 3000000000
8 Cell Point India Limited Mohan Prasad Panday Managing director Any other transaction Sales Commission 5000000000000 0 4000000000000 2025-05-29 4000000000000 411686900000 2226892900000
9 Cell Point India Limited Lakshmi Narasimha Electronics LLP A firm, in which andirector, manager ornhis relative is a partner Any other transaction Loan 2875000000000 0 2875000000000 2025-05-29 2875000000000 0 2875000000000
Total value of transaction during the reporting period 9771000000000